First Trust NYSE® Arca® Biotechnology Index Fund (FBT) is a First Trust ETF with a 0.55% expense ratio, 31 holdings and $3.0B in net assets. Largest sector: Healthcare (100%).
Fee
0.55%
expense ratio
Net assets
$3.0B
Launched
Jun 19, 2006
Holdings
31
as of Oct 23, 2026
Top 10 weight
35.9%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
—
Benchmark
—
FBT's holdings are as of Oct 23, 2026.
Healthcare
100.0%
1
GMAB
GENMAB A/S SP ADR ADR
3.88%
2
HALO
Halozyme Therapeutics
3.74%
3
BIIB
BIOGEN
3.65%
4
EXEL
Exelixis
3.54%
5
REGN
REGENERON PHARMACEUTICALS
3.54%
6
ALKS
Alkermes
3.53%
7
UTHR
United Therapeutics
3.52%
8
ONC
BEONE MEDICINES LTD-ADR
3.50%
9
AMGN
AMGEN
3.48%
10
VCYT
VERACYTE
3.48%
11
ARGX
ARGENX
3.48%
12
ADMA
ADMA Biologics
3.39%
13
GILD
GILEAD SCIENCES
3.39%
14
VRTX
VERTEX PHARMACEUTICALS
3.38%
15
INCY
INCYTE
3.37%
16
BMRN
BioMarin Pharmaceutical
3.36%
17
RGEN
Repligen
3.35%
18
NEO
NeoGenomics
3.34%
19
NTRA
Natera
3.31%
20
NBIX
Neurocrine Biosciences
3.29%
21
TECH
BIO TECHNE
3.29%
22
BRKR
Bruker
3.22%
23
TGTX
TG Therapeutics
3.22%
24
ILMN
ILLUMINA
3.18%
25
ALNY
Alnylam Pharmaceuticals
3.17%
1–25 of 31
Funds listed by how much of their largest holdings they share with FBT — not a ranking.
Data from First Trust; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.